Samuel Curtis
banner
samuelmcurtis.com
Samuel Curtis
@samuelmcurtis.com
AI x biotech policy
Many other points were covered in the comment, including survey responses, which add more color to researchers' attitudes (n=54; ~75% European respondents).

We value feedback from both scientists and policy researchers—please reach out!
December 6, 2024 at 6:51 PM
We also express concern about the present lack of incentives or straightforward mechanisms to obtain substantive input from scientists on policy matters related to chem-bio AI models. This is a fundamental challenge that we'll need to address in the years to come.
December 6, 2024 at 6:51 PM
One issue we draw attention to is that claims of potential biosecurity risks have been used and could continue to be used as a pretext to delay or withhold from sharing a model or method to advance a commercial interest.
December 6, 2024 at 6:51 PM
Our goal was to share perspectives and considerations that represent the views of Rosetta Commons and the broader biomolecular structure analysis, prediction, and design communities. It was supplemented by scientists' input solicited via a workshop, roundtable discussion, and survey.
December 6, 2024 at 6:51 PM